NCT02899078 2025-05-18Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney CancerUniversity of California, DavisPhase 1/2 Completed31 enrolled 11 charts
NCT02599324 2023-11-18Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary TumorsPharmacyclics LLC.Phase 1/2 Completed263 enrolled 34 charts